Australia markets close in 5 hours 34 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
10.52-0.06 (-0.57%)
At close: 4:00PM EST

Teva Pharmaceutical Industries Limited

5 Basel Street
Petah Tikva 4951033
Israel
972 3 914 8213
http://www.tevapharm.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees37,100

Key executives

NameTitlePayExercisedYear born
Mr. Kare SchultzPres, CEO & Director5.6MN/A1961
Mr. Eliyahu Sharon KalifExec. VP & CFO655.76kN/A1973
Dr. Hafrun FridriksdottirExec. VP of Global R&D2.48MN/A1962
Mr. Brendan P. O'GradyExec. VP of North America Commercial1.56MN/A1967
Mr. Gianfranco NazziExec. VP of International Markets Commercial2.15MN/A1970
Mr. Eric DrapéExec. VP of Global OperationsN/AN/A1962
Mr. Andrew J. Weil CPAChief Accounting OfficerN/AN/A1967
Mr. Kevin C. MannixSr. VP of Investor RelationsN/AN/AN/A
Mr. David M. StarkExec. VP & Chief Legal OfficerN/AN/A1969
Ms. Lori QueisserSr. VP & Global Compliance OfficerN/AN/AN/A
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Corporate governance

Teva Pharmaceutical Industries Limited’s ISS governance QualityScore as of 3 December 2020 is 3. The pillar scores are Audit: 3; Board: 1; Shareholder rights: 6; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.